• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    11.45 Down 0.83(6.76%) Apr 17, 4:00PM EDT
    |After Hours : 11.50 Up 0.05 (0.40%) Apr 17, 4:01PM EDT
    Add to Portfolio
    Prev Close:12.28
    Open:12.09
    Bid:11.45 x 500
    Ask:11.99 x 1000
    1y Target Est:23.55
    Beta:5.64
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:11.41 - 12.09
    52wk Range:10.85 - 18.48
    Volume:2,731,055
    Avg Vol (3m):1,721,000
    Market Cap:1.19B
    P/E (ttm):N/A
    EPS (ttm):-1.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXDown 6.76%1.19B
    BAXDown 0.34%37.93B
    SHPGUp 0.10%47.81B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):117.52
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.95
    Quarterly EPS Est (Mar-15) :-0.30
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.11

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback